 Cytomegalovirus infection delayed platelet recovery bone marrow transplantation pathogenic effect cytomegalovirus CMV infection hematopoietic recovery bone marrow transplantation BMT recipients autologous BMT recipients allogeneic BMT HLA-identical siblings Indications autologous BMT lymphomas acute leukemias allogeneic BMT various malignancies aplastic anemia Patients study groups CMV-positive CMV-negative basis CMV status pretransplant CMV-negative patients CMV-negative local transfusion policy allogeneic BMT recipients platelet recovery CMV-positive patients CMV-negative patients platelets cells/microL days days difference true patients acute graft-versus-host disease grade platelets cells/microL days days autologous BMT negative effect platelet recovery present patients lymphomas absent patients acute leukemias Patients acute leukemias delayed recovery platelets granulocytes autologous BMT irrespective CMV status due original stem cell disorder Platelet recovery CMV-positive autologous BMT recipients lymphomas platelets cells/microL days days presence CMV infection effect recovery granulocytes autologous allogeneic BMT data CMV infection delayed platelet recovery BMT autologous BMT underlying disease ie acute leukemia determinant hematopoiesis BMT